Join the Hives group to help and get support from people like you.
Hives News
Related terms: Wheals and Welts
Study Compares Benefits, Harms of Treatments for Chronic Hives
WEDNESDAY, July 23, 2025 – Omalizumab and remibrutinib may be the most effective treatments for reducing hives, itch, and swelling with chronic urticaria, according to a study published online July...
What Are The Best Treatments For Chronic Hives?
FRIDAY, July 18, 2025 — Hives can drive a person crazy, covering parts of the body with maddeningly itchy welts. Now, a new evidence review has identified the most effective treatments for people who ...
Urticaria Reported in Trial of Investigational HIV mRNA Vaccines
MONDAY, May 5, 2025 – Urticaria is seen in association with experimental HIV-1 mRNA vaccination, according to a study published online April 29 in the Annals of Internal Medicine. Sharon A. Riddler,...
FDA Approves Dupixent for Chronic Spontaneous Urticaria
WEDNESDAY, April 23, 2025 – The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adults and adolescents with chronic spontaneous urticaria. The approval is...
Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment
TUESDAY, March 11, 2025 – For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H1-antihistamines, administration of the oral, highly selective Bruton's...
FDA Approves Quzyttir (cetirizine) Injection for the Treatment of Acute Urticaria
October 11, 2019 - The U.S. Food and Drug Administration (FDA) has approved Quzyttir (cetirizine hydrochloride) injection for the treatment of acute urticaria in adults and children 6 months of age...
Further information
Related condition support groups
Related drug support groups
Benadryl, Zyrtec, Claritin, diphenhydramine, Allegra, loratadine, promethazine, Dupixent, famotidine, view more... cetirizine, Xolair, doxepin, Phenergan, fexofenadine, omalizumab, cyproheptadine, dupilumab, Xyzal